Randomized, Multicenter, Phase II Study of CO-101 Versus...

Journal of Clinical Oncology 2013 / 12 Vol. 31; Iss. 35

Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity

Poplin, E., Wasan, H., Rolfe, L., Raponi, M., Ikdahl, T., Bondarenko, I., Davidenko, I., Bondar, V., Garin, A., Boeck, S., Ormanns, S., Heinemann, V., Bassi, C., Evans, T. R. J., Andersson, R., Hahn,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2013.51.0826
Date:
December, 2013
File:
PDF, 1.52 MB
english, 2013
Conversion to is in progress
Conversion to is failed